Ablaze: RayzeBio-Partnered Startup Focused on Bringing Radiopharmaceuticals to China
Ablaze has aligned itself with RayzeBio, giving Ablaze a solid start with an in-licensing agreement to bring Rayze's products to the greater China market.
Read full article »
Ablaze is a China-based pharmaceutical company that discovers and develops radiopharmaceutical therapies for the treatment of cancer.
Read more